TH.TO
Theratechnologies Inc
Price:  
1.77 
CAD
Volume:  
7,973.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TH.TO EV/EBITDA

-190.1%
Upside

As of 2024-05-18, the EV/EBITDA ratio of Theratechnologies Inc (TH.TO) is -31.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TH.TO's latest enterprise value is 110.46 mil CAD. TH.TO's TTM EBITDA according to its financial statements is -3.52 mil CAD. Dividing these 2 quantities gives us the above TH.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.5x - 10.4x 9.0x
Forward P/E multiples 4.7x - 15.8x 10.2x
Fair Price (1.38) - (1.68) (1.59)
Upside -177.9% - -194.7% -190.1%
1.77 CAD
Stock Price
(1.59) CAD
Fair Price

TH.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 -29.27
2024-05-16 -29.53
2024-05-15 -29.66
2024-05-14 -29.40
2024-05-13 -27.81
2024-05-10 -27.81
2024-05-09 -28.47
2024-05-08 -27.81
2024-05-07 -28.34
2024-05-06 -28.34
2024-05-03 -29.53
2024-05-02 -29.27
2024-05-01 -29.53
2024-04-30 -29.27
2024-04-29 -29.53
2024-04-26 -29.66
2024-04-25 -29.66
2024-04-24 -30.32
2024-04-23 -30.85
2024-04-22 -30.32
2024-04-19 -29.80
2024-04-18 -29.80
2024-04-17 -29.66
2024-04-16 -29.80
2024-04-15 -29.66
2024-04-12 -30.85
2024-04-11 -32.70
2024-04-10 -32.44
2024-04-09 -33.50
2024-04-08 -31.38
2024-04-05 -32.70
2024-04-04 -33.10
2024-04-03 -34.68
2024-04-02 -34.42
2024-04-01 -34.02
2024-03-28 -35.35
2024-03-27 -32.04
2024-03-26 -31.25
2024-03-25 -29.80
2024-03-22 -28.74
2024-03-21 -28.34
2024-03-20 -27.68
2024-03-19 -27.55
2024-03-18 -27.81
2024-03-15 -28.21
2024-03-14 -27.55
2024-03-13 -27.55
2024-03-12 -27.55
2024-03-11 -27.81
2024-03-08 -27.95